about
Paraneoplastic antigen Ma2 autoantibodies as specific blood biomarkers for detection of early recurrence of small intestine neuroendocrine tumorsThe pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumorsMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursRare Neoplasia of the StomachRole of computed tomography angiography in detection and staging of small bowel carcinoid tumorsFrom targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumorsNonruminant Nutrition Symposium: Involvement of gut neural and endocrine systems in pathological disorders of the digestive tractPancreatic endocrine neoplasms: a current update on genetics and imaging.PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literatureSurgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentImaging of gastroenteropancreatic neuroendocrine tumorsPathologic research update of colorectal neuroendocrine tumorsGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsNeuroendocrine tumors of the gastro-entero-pancreatic systemNovel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomasThe somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cellsAltered MENIN expression disrupts the MAFA differentiation pathway in insulinomaGastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from AsiaEverolimus-based combination for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): biological rationale and critical review of published data.Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic cancer.Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study.MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progressionSomatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites.Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes.Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group.VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.
P2860
Q21089988-3098169B-EABF-4D90-ACEA-9B22AC6D84F8Q26740374-02DBE43D-FD6E-4FC7-AE11-03876F9B1DA7Q26751659-3D022EB3-972E-43BA-AFD4-F17F2B6DA22DQ26775428-10337EE7-E340-4B69-80E4-5D868F5F8575Q26782190-988DB2EE-5228-4541-A323-197446B1D5E3Q26822011-D512F550-5162-46FB-85D6-952D7551F0B0Q26823057-44C7DAEC-3BF1-4AE8-A2B6-12B76C332810Q26852418-3FCCF625-FF8A-41E6-83A5-0F10DA2E3916Q26992201-71853AE9-614A-4AE7-A05B-B115619D4ECAQ27026980-1BC0F226-99CF-4A76-927F-492B6D82FF08Q28083433-B6204417-B6D7-4B6F-97D2-DAD829AEE679Q28238305-7CE20D5E-6EDE-4C9A-8795-856D073F17E9Q28279323-B19250EF-222D-4F0A-8EB4-7737D41BF223Q28290833-A84D04FD-838E-4E77-9192-255B7DDD567AQ28294432-C752F7A4-AE80-4231-A4AC-B5B8FA30BBC7Q28298788-E76E7B5B-F1C8-4C83-9855-13B899D1FBAEQ28484664-04951BAE-506B-4548-803F-206CF5D9DA37Q28577962-B9F412E2-E779-4B01-969C-ABA390D7CAE0Q30249051-D4F430A0-26F8-4E67-AB28-33920801BA99Q30252003-7A884B3A-6643-439B-B52A-DA0183378BB5Q30364864-19D2D62D-05C7-4622-9997-46A748584811Q30884528-EE91F9E0-8143-472E-A906-F43FA9E4A876Q30884794-4EF5C5B1-2ED1-449C-873D-24A8024ED682Q30938609-45705FA5-9651-4C66-91AA-D0D640D02752Q31064727-285C081C-CDA0-40F1-9686-EA0562A8862EQ31170918-A463A575-F32F-4B86-BBC3-F70E44B68BBCQ33388860-697355BF-85C2-4320-BD48-F7AF588C38C3Q33397018-BBF139FB-23AA-4DFD-939D-E67C5F2EABDEQ33520915-7B281FFE-4F29-49EC-92E8-3941ACE0411DQ33598860-9CB88826-F4D8-43F6-8355-2BA4BC5430BCQ33601383-8A750803-ECFF-465E-8DB9-D80EDDC7E461Q33658301-6C461E34-593B-4D35-A507-87E8FAB52291Q33708663-BE6C3F21-A2D1-415F-8128-21B0C7E0812EQ33753449-1ACD873A-AC7B-49F2-BE79-15437C7801C8Q33767666-85381FD6-5175-47DB-8008-A6792D5E9C1EQ33782024-6A4F0609-CA13-4FC6-9069-F1C75D2C095FQ33812900-7E7BA1E6-686F-40A7-9237-6A9CA6AD4570Q33823783-E8E90AB1-4449-46CB-B3B1-A05EBD9A3789Q33894587-747AEF20-AD1B-47FD-B5AC-89A0B9B7BEE6Q33926020-AFF49330-B589-42DE-ADA7-65C652D73231
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gastroenteropancreatic neuroendocrine tumours
@ast
Gastroenteropancreatic neuroendocrine tumours
@en
Gastroenteropancreatic neuroendocrine tumours
@nl
type
label
Gastroenteropancreatic neuroendocrine tumours
@ast
Gastroenteropancreatic neuroendocrine tumours
@en
Gastroenteropancreatic neuroendocrine tumours
@nl
prefLabel
Gastroenteropancreatic neuroendocrine tumours
@ast
Gastroenteropancreatic neuroendocrine tumours
@en
Gastroenteropancreatic neuroendocrine tumours
@nl
P2093
P50
P3181
P1433
P1476
Gastroenteropancreatic neuroendocrine tumours
@en
P2093
Anders Sundin
Daniel C Chung
Eric P Krenning
Greg A Kaltsas
Irvin M Modlin
Kjell Oberg
Martyn Caplin
Ola Nilsson
Philippe Ruszniewski
Ramon Salazar
P3181
P356
10.1016/S1470-2045(07)70410-2
P407
P577
2008-01-01T00:00:00Z